Subscribe to RSS
DOI: 10.1055/a-2792-9544
The Role of Arterial Stiffness in the Prognosis, Assessment, and Treatment of Patients with Peripheral Artery Disease: A Comprehensive Review
Authors
Abstract
Peripheral artery disease (PAD) is a prevalent and disabling vascular condition characterized by progressive atherosclerotic narrowing and stiffening of peripheral arteries. Arterial stiffness, most accurately measured by pulse wave velocity (PWV), has gained prominence as a critical biomarker in the assessment and management of PAD. Unlike traditional diagnostic tools that focus primarily on anatomical lesions, PWV offers dynamic insights into vascular function, elasticity, and systemic cardiovascular risk. Elevated PWV has been consistently associated with adverse outcomes in PAD patients, including critical limb ischemia, restenosis following angioplasty, amputation, and cardiovascular mortality. It not only reflects disease severity but also facilitates early risk stratification, informs treatment selection, and enables monitoring of therapeutic efficacy. Studies have shown that reductions in arterial stiffness following angioplasty, pharmacological therapy, or lifestyle interventions correlate with improved limb perfusion and long-term clinical outcomes. Moreover, in elderly PAD patients, arterial stiffness often coexists with frailty—another key predictor of poor prognosis. Emerging evidence suggests that both conditions may share pathophysiological pathways related to vascular aging and sarcopenia. The integration of PWV into routine PAD evaluation may thus offer a more holistic understanding of patient risk and resilience. Given its diagnostic, prognostic, and therapeutic utility, arterial stiffness—particularly as assessed by PWV—should be considered an essential parameter in PAD management. Incorporating this measurement into clinical practice holds significant potential to improve individualized care, reduce complications, and enhance overall patient outcomes.
Keywords
peripheral artery disease - vascular stiffness - pulse wave velocity - vascular diseases - atherosclerosis - lower extremity - risk factorsPublication History
Received: 08 January 2026
Accepted: 19 January 2026
Article published online:
06 February 2026
© 2026. International College of Angiology. This article is published by Thieme.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Golledge J. Update on the pathophysiology and medical treatment of peripheral artery disease. Nat Rev Cardiol 2022; 19 (07) 456-474
- 2 Anghel R, Adam CA, Marcu DTM. et al. Cardiac rehabilitation in peripheral artery disease in a tertiary center-impact on arterial stiffness and functional status after 6 months. Life (Basel) 2022; 12 (04) 601
- 3 Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25 (05) 932-943
- 4 Mendes-Pinto D, Rodrigues-Machado MDG, Avelar GL, Navarro TP, Dardik A. Arterial stiffness predicts amputation and death in patients with chronic limb-threatening ischemia. J Vasc Surg 2021; 74 (06) 2014-2022.e4
- 5 Kalbaugh CA, Taylor SM, Blackhurst DW, Dellinger MB, Trent EA, Youkey JR. One-year prospective quality-of-life outcomes in patients treated with angioplasty for symptomatic peripheral arterial disease. J Vasc Surg 2006; 44 (02) 296-302 , discussion 302–303
- 6 Husmann M, Jacomella V, Thalhammer C, Amann-Vesti BR. Markers of arterial stiffness in peripheral arterial disease. Vasa 2015; 44 (05) 341-348
- 7 Zhu Z, Yu H, Jiang M, Wu H, Wang J, Xu F. Status and influencing factors of frailty in patients with restenosis after percutaneous transluminal angioplasty for peripheral arterial disease: a cross-sectional study. Medicine (Baltimore) 2023; 102 (29) e34465
- 8 Höbaus C, Roller-Wirnsberger R, Gerit-Holger S. Peripheral arterial disease and loss of physical function: just two old friends?. Atherosclerosis 2017; 257: 246-247
- 9 Avolio A. Arterial stiffness. Pulse (Basel) 2013; 1 (01) 14-28
- 10 Allen MF, Pekas EJ, Park SY. Arterial stiffness as a prognostic marker for peripheral artery disease risk: clinical relevance and considerations. JACC Asia 2023; 3 (02) 298-300
- 11 Karimpour P, May JM, Kyriacou PA. Photoplethysmography for the assessment of arterial stiffness. Sensors (Basel) 2023; 23 (24) 9882
- 12 Buso G, Faggin E, Bressan A. et al. Biomarkers of neutrophil activation in patients with symptomatic chronic peripheral artery disease predict worse cardiovascular outcome. Biomedicines 2023; 11 (03) 866
- 13 Lin CC, Li CI, Liu CS, Lin CH, Yang SY, Li TC. Prediction of all-cause and cardiovascular mortality using ankle-brachial index and brachial-ankle pulse wave velocity in patients with type 2 diabetes. Sci Rep 2022; 12 (01) 11053
- 14 Zahner GJ, Gruendl MA, Spaulding KA. et al. Association between arterial stiffness and peripheral artery disease as measured by radial artery tonometry. J Vasc Surg 2017; 66 (05) 1518-1526
- 15 Toprak K, Balaban İ, Pala S. The effect of successful lower extremity revascularization on aortic stiffness in patients with peripheral arterial disease. Vascular 2023; 31 (06) 1253-1261
- 16 Parmenter BJ, Mavros Y, Ritti Dias R, King S, Fiatarone Singh M. Resistance training as a treatment for older persons with peripheral artery disease: a systematic review and meta-analysis. Br J Sports Med 2020; 54 (08) 452-461
- 17 Ochi M, Kohara K, Tabara Y. et al. Arterial stiffness is associated with low thigh muscle mass in middle-aged to elderly men. Atherosclerosis 2010; 212 (01) 327-332
- 18 Wu Z, Jiang Y, Zhu Q. et al. Combined evaluation of arterial stiffness and blood pressure promotes risk stratification of peripheral arterial disease. JACC Asia 2023; 3 (02) 287-297
- 19 Qian Z, Huang Y, Zhang Y. et al. Metabolic clues to aging: exploring the role of circulating metabolites in frailty, sarcopenia and vascular aging related traits and diseases. Front Genet 2024; 15: 1353908
- 20 Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55 (13) 1318-1327
- 21 Ben-Shlomo Y, Spears M, Boustred C. et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol 2014; 63 (07) 636-646
- 22 Laurent S, Boutouyrie P, Asmar R. et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37 (05) 1236-1241
- 23 Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007; 45 (Suppl S): S5-S67
- 24 Adam DJ, Beard JD, Cleveland T. et al; BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005; 366 (9501) 1925-1934
- 25 Conte MS, Bradbury AW, Kolh P. et al; GVG Writing Group. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg 2019; 69 (6S): 3S , e40
- 26 Aboyans V, Ricco JB, Bartelink MEL. et al; ESC Scientific Document Group. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 2018; 39 (09) 763-816